Literature DB >> 30151601

Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.

Giulio Ruberto1, Carlo Bruttini2, Carmine Tinelli3, Lorenzo Cavagna4, Alessandro Bianchi2, Giovanni Milano2.   

Abstract

PURPOSE: We aimed to find earlier morphological and functional alterations in the retinas of patients treated with hydroxychloroquine (HCQ). This was a prospective cohort study.
METHODS: We examined 33 patients (mean age, 57.14 [SD, 11.02] years) who were affected by various types of rheumatic diseases. The mean treatment period was 124.7 [SD, 99.4] months, and the mean total drug intake was 5.41 [SD, 3.34] g daily at baseline. The control group consisted of 28 subjects with a mean age of 61.25 [SD, 2.16 years]. The set of tests encompassed best-corrected visual acuity (BCVA), a multifocal electroretinogram (mfERG), spectral-domain optical coherence tomography (SD-OCT), fundus auto fluorescence (FAF), the 10-2 automated visual field (VF) test (10-2 VF), and frequency-doubling technology (FDT).
RESULTS: The mfERG P1 wave density amplitudes decreased in all the rings, from 31.10 to 28.02 (p = 0.008) in the first ring, and from 18.29 to 16.55 [p < 0.001], from 12.050 to 10.91 [p = 0.002], from 9.53 to 8.69 [p = 0.003], and from 8.25 to 7.48 [p = 0.001] nanovolts/degree2 in rings 2, 3, 4, and 5, respectively. A significant reduction was found also in the N1 wave in the second ring. The SD-OCT retinal thickness measurement revealed significant thinning in five sectors, including the outer and inner nasal sectors, the outer and inner temporal sectors, and the inner superior sector. The 10-2 VF mean deviation paradoxically improved, while minimal FAF alterations in the retinal pigment epithelium were found in eight eyes.
CONCLUSIONS: mfERGs and SD-OCT were altered in our patients before significant retinal changes occurred.

Entities:  

Keywords:  Frequency-doubling technology; Hydroxychloroquine; Maculopathy; SD-OCT; Visual field; mfERG

Mesh:

Substances:

Year:  2018        PMID: 30151601     DOI: 10.1007/s00417-018-4103-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

Review 1.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

2.  Subjective and objective screening tests for hydroxychloroquine toxicity.

Authors:  Catherine Cukras; Nancy Huynh; Susan Vitale; Wai T Wong; Fredrick L Ferris; Paul A Sieving
Journal:  Ophthalmology       Date:  2014-10-14       Impact factor: 12.079

3.  Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.

Authors:  Lucia Tanga; Marco Centofanti; Francesco Oddone; Mariacristina Parravano; Vincenzo Parisi; Lucia Ziccardi; Barbara Kroegler; Roberto Perricone; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-21       Impact factor: 3.117

4.  Chloroquine retinopathy in the rhesus monkey.

Authors:  A R Rosenthal; H Kolb; D Bergsma; D Huxsoll; J L Hopkins
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-12       Impact factor: 4.799

5.  Frequency doubling technology perimetry using a 24--2 stimulus presentation pattern.

Authors:  C A Johnson; G A Cioffi; E M Van Buskirk
Journal:  Optom Vis Sci       Date:  1999-08       Impact factor: 1.973

6.  Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.

Authors:  Raj K Maturi; Minzhong Yu; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2004-07

7.  Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence.

Authors:  S Kellner; S Weinitz; U Kellner
Journal:  Br J Ophthalmol       Date:  2009-08-18       Impact factor: 4.638

8.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

9.  Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review : Review of mfERG ring ratios in Plaquenil toxicity.

Authors:  Jonathan S Lyons; Matthew L Severns
Journal:  Doc Ophthalmol       Date:  2008-05-09       Impact factor: 2.379

10.  Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.

Authors:  David J Browning; Chong Lee
Journal:  Clin Ophthalmol       Date:  2014-07-25
View more
  3 in total

Review 1.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

2.  Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.

Authors:  Koushik Mondal; Hunter Porter; Jerome Cole; Hemang K Pandya; Sandip K Basu; Sufiya Khanam; Chi-Yang Chiu; Vinay Shah; Daniel J Stephenson; Charles E Chalfant; Nawajes Mandal
Journal:  Mol Neurobiol       Date:  2022-04-15       Impact factor: 5.682

3.  Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment.

Authors:  Salvatore Parrulli; Mariano Cozzi; Matteo Airaldi; Francesco Romano; Francesco Viola; Piercarlo Sarzi-Puttini; Giovanni Staurenghi; Alessandro Invernizzi
Journal:  Clin Exp Ophthalmol       Date:  2022-05-14       Impact factor: 4.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.